Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Giuseppe Fasolino actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 12 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landenniveau. Duik in de details door op de stippen te klikken.
Onderzoeksoutput
-
A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Everaert, H. & Neyns, B., 1 mei 2021, In : Cancers (Basel). 13, 9, 13 blz., 2010.Onderzoeksoutput: Article
Open AccessBestand20 Downloads (Pure) -
Choriocapillaris Assessment In Patients Under Mek-Inhibitor Therapy For Cutaneous Melanoma: An Optical Coherence Tomography Angiography Study
Fasolino, G., Awada, G., Koulalis, J. S., Neyns, B., Van Elderen, P., Kuijpers, R. W., Nelis, P. & Ten Tusscher, M., 2021, In : Seminars in Ophthalmology. blz. 1-7 7 blz.Onderzoeksoutput: Article
-
Interim safety and efficacy results of a phase II clinical trial on trametinib and low-dose dabrafenib in patients with advanced BRAFV600 wild-type melanoma
Awada, G., Schwarze, J. K., Reijmen, E., Goyvaerts, C., Fasolino, G., Aspeslagh, S. & Neyns, B., 2020, In : Annals of Oncology. 31, S1, blz. S10-S10Onderzoeksoutput: Meeting abstract (Journal)
Open AccessBestand37 Downloads (Pure) -
Interim safety and efficacy results of a phase II clinical trial on trametinib and low-dose dabrafenib in patients with advanced BRAFV600 wild-type melanoma
Awada, G., Schwarze, J. K., Reijmen, E., Goyvaerts, C., Fasolino, G., Aspeslagh, S. & Neyns, B., 2020.Onderzoeksoutput: Poster
Bestand6 Downloads (Pure) -
A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
Pece, A., Milani, P., Monteleone, C., Trombetta, C. J., De Crecchio, G., Fasolino, G., Matranga, D., Cillino, S. & Vadalà, M., nov 2015, In : Graefe's Archive for Clinical and Experimental Ophthalmology. 253, 11, blz. 1867-1872 6 blz.Onderzoeksoutput: Article
13 Citaten (Scopus)
Activiteiten
-
ocular toxicity related to new oncological treatment
Giuseppe Fasolino (Speaker)19 jun 2021Activiteit: Talk or presentation at a conference
-
-
brussel retina meeting
Giuseppe Fasolino (Chair)4 apr 2019 → 6 apr 2019Activiteit: Participating in or organizing an event at an external academic organisation
-
diabetic retinopathy
Giuseppe Fasolino (Speaker)28 nov 2019Activiteit: Talk or presentation at a conference
-
subtreshold laser treatment in diabetic retinopathy
Giuseppe Fasolino (Speaker)7 sep 2019Activiteit: Talk or presentation at a conference